{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:17:36Z","timestamp":1773148656451,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Infantile pustular psoriasis (IPP) is an extremely rare skin disease associated with genetic factors. Gene mutations of IL36RN (interleukin-36 receptor antagonist), CARD14 (caspase recruitment family member 14), and AP1S1 (the \u03c31C subunit of the adaptor protein complex 1) had been identified to be involved in the pathogenesis of IPP. IPP usually develops with no preceding psoriasis vulgaris (PV) or familial history. Here, we report a case of a 6-month-old infant and make the diagnosis of IPP by a series of examinations; subsequently, by detecting coexistent mutations of IL36RN and CARD14, the diagnosis is intensified from a genetic point of view. We treated the child with traditional oral and topical drugs regardless of the commonly used acitretin considering its potential side effects, such as skeletal toxicity, and the lesions got conspicuous improvement with much reduction of inflammation. Owing to the genetic mutation of IL-36, there had been reported cases focusing on anti-IL36 biological agents in the treatment of IPP, and it could be a new weapon to treat and improve such IL-36RN-deficient skin diseases.<\/jats:p>","DOI":"10.3389\/fgene.2022.1035037","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T19:32:16Z","timestamp":1673379136000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations"],"prefix":"10.3389","volume":"13","author":[{"given":"Xinyun","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfa","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yantao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","article-title":"Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin","volume":"90","author":"Akiyama","year":"2018","journal-title":"J. Dermatol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMc1811317","article-title":"Inhibition of the interleukin-36 pathway for the treatment of generalized pustular psoriasis","volume":"380","author":"Bachelez","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","article-title":"Regulation and function of interleukin-36 cytokines","volume":"281","author":"Bassoy","year":"2018","journal-title":"Immunol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1525-1470.2010.01084.x","article-title":"Generalized pustular psoriasis in childhood","volume":"27","author":"De Oliveira","year":"2010","journal-title":"Pediatr. Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/09546630802132643","article-title":"Acitretin is a safe treatment option for infantile pustular psoriasis","volume":"19","author":"Ergin","year":"2008","journal-title":"J. Dermatol. Treat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1001\/archderm.1984.01650450056018","article-title":"Familial juvenile generalized pustular psoriasis","volume":"120","author":"Hubler","year":"1984","journal-title":"Arch. Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bjd.12548","article-title":"Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations","volume":"170","author":"Huffmeier","year":"2014","journal-title":"Br. J. Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jaci.2014.09.043","article-title":"IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis","volume":"135","author":"Hussain","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/jid.2013.214","article-title":"Mutations in IL36RN in patients with generalized pustular psoriasis","volume":"133","author":"K\u00f6rber","year":"2013","journal-title":"J. Invest. Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e14814","DOI":"10.1111\/dth.14814","article-title":"Drug survival in the treatment of generalized pustular psoriasis: A retrospective multicenter study","volume":"34","author":"Kromer","year":"2021","journal-title":"Dermatol Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/bjd.17392","article-title":"Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population","volume":"180","author":"Li","year":"2019","journal-title":"Br. J. Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jdermsci.2014.08.007","article-title":"Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with\/without psoriasis vulgaris","volume":"76","author":"Li","year":"2014","journal-title":"J. Dermatol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1525-1470.2001.018003188.x","article-title":"Childhood psoriasis: A clinical review of 1262 cases","volume":"18","author":"Morris","year":"2001","journal-title":"Pediatr. Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/exd.14171","article-title":"Generalized pustular psoriasis-Dawn of a new era in targeted immunotherapy","volume":"29","author":"Neuhauser","year":"2020","journal-title":"Exp. Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/jid.2014.269","article-title":"Variant analysis of CARD14 in a Chinese Han population with psoriasis vulgaris and generalized pustular psoriasis","volume":"134","author":"Qin","year":"2014","journal-title":"J. Invest. Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1056\/NEJMc091749","volume":"361","author":"Salem","year":"2009","journal-title":"Psoriasis. N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.dsi.2011.01.002","article-title":"Infantile generalized pustular psoriasis: A case report and review of the literature","volume":"29","author":"Su","year":"2011","journal-title":"Dermatol Sin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist","volume":"133","author":"Sugiura","year":"2013","journal-title":"J. Invest. Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jdermsci.2016.11.008","article-title":"Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes","volume":"85","author":"Wang","year":"2017","journal-title":"J. Dermatol Sci."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1035037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T19:32:19Z","timestamp":1673379139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1035037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":21,"alternative-id":["10.3389\/fgene.2022.1035037"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1035037","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1035037"}}